178 related articles for article (PubMed ID: 19307367)
1. Colorimetric high-throughput screen for detection of heme crystallization inhibitors.
Rush MA; Baniecki ML; Mazitschek R; Cortese JF; Wiegand R; Clardy J; Wirth DF
Antimicrob Agents Chemother; 2009 Jun; 53(6):2564-8. PubMed ID: 19307367
[TBL] [Abstract][Full Text] [Related]
2. Simple colorimetric inhibition assay of heme crystallization for high-throughput screening of antimalarial compounds.
Huy NT; Uyen DT; Maeda A; Trang DT; Oida T; Harada S; Kamei K
Antimicrob Agents Chemother; 2007 Jan; 51(1):350-3. PubMed ID: 17088494
[TBL] [Abstract][Full Text] [Related]
3. Heme Detoxification in the Malaria Parasite: A Target for Antimalarial Drug Development.
de Villiers KA; Egan TJ
Acc Chem Res; 2021 Jun; 54(11):2649-2659. PubMed ID: 33982570
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hemozoin formation in Plasmodium falciparum trophozoite extracts by heme analogs: possible implication in the resistance to malaria conferred by the beta-thalassemia trait.
Martiney JA; Cerami A; Slater AF
Mol Med; 1996 Mar; 2(2):236-46. PubMed ID: 8726466
[TBL] [Abstract][Full Text] [Related]
5. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
6. A novel way to grow hemozoin-like crystals in vitro and its use to screen for hemozoin inhibiting antimalarial compounds.
Thomas V; Góis A; Ritts B; Burke P; Hänscheid T; McDonnell G
PLoS One; 2012; 7(7):e41006. PubMed ID: 22815894
[TBL] [Abstract][Full Text] [Related]
7. Hemozoin and antimalarial drug discovery.
Fong KY; Wright DW
Future Med Chem; 2013 Aug; 5(12):1437-50. PubMed ID: 23919553
[TBL] [Abstract][Full Text] [Related]
8. Quinoline drug-heme interactions and implications for antimalarial cytostatic versus cytocidal activities.
Gorka AP; de Dios A; Roepe PD
J Med Chem; 2013 Jul; 56(13):5231-46. PubMed ID: 23586757
[TBL] [Abstract][Full Text] [Related]
9. Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization.
Sandlin RD; Carter MD; Lee PJ; Auschwitz JM; Leed SE; Johnson JD; Wright DW
Antimicrob Agents Chemother; 2011 Jul; 55(7):3363-9. PubMed ID: 21518844
[TBL] [Abstract][Full Text] [Related]
10. Mode of action of quinoline antimalarial drugs in red blood cells infected by
Kapishnikov S; Staalsø T; Yang Y; Lee J; Pérez-Berná AJ; Pereiro E; Yang Y; Werner S; Guttmann P; Leiserowitz L; Als-Nielsen J
Proc Natl Acad Sci U S A; 2019 Nov; 116(46):22946-22952. PubMed ID: 31659055
[TBL] [Abstract][Full Text] [Related]
11. High-Throughput Screening and Prediction Model Building for Novel Hemozoin Inhibitors Using Physicochemical Properties.
Huy NT; Chi PL; Nagai J; Dang TN; Mbanefo EC; Ahmed AM; Long NP; Thoa LT; Hung LP; Titouna A; Kamei K; Ueda H; Hirayama K
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27919903
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of heme crystal growth by antimalarials and other compounds: implications for drug discovery.
Chong CR; Sullivan DJ
Biochem Pharmacol; 2003 Dec; 66(11):2201-12. PubMed ID: 14609745
[TBL] [Abstract][Full Text] [Related]
13. Artemisinin-Based Drugs Target the Plasmodium falciparum Heme Detoxification Pathway.
Ribbiso KA; Heller LE; Taye A; Julian E; Willems AV; Roepe PD
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33495226
[TBL] [Abstract][Full Text] [Related]
14. Cytostatic versus cytocidal activities of chloroquine analogues and inhibition of hemozoin crystal growth.
Gorka AP; Alumasa JN; Sherlach KS; Jacobs LM; Nickley KB; Brower JP; de Dios AC; Roepe PD
Antimicrob Agents Chemother; 2013 Jan; 57(1):356-64. PubMed ID: 23114783
[TBL] [Abstract][Full Text] [Related]
15. A non-radiolabeled heme-GSH interaction test for the screening of antimalarial compounds.
Garavito G; Monje MC; Maurel S; Valentin A; Nepveu F; Deharo E
Exp Parasitol; 2007 Jul; 116(3):311-3. PubMed ID: 17336296
[TBL] [Abstract][Full Text] [Related]
16. Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors.
Hempelmann E
Parasitol Res; 2007 Mar; 100(4):671-6. PubMed ID: 17111179
[No Abstract] [Full Text] [Related]
17. A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds.
Ncokazi KK; Egan TJ
Anal Biochem; 2005 Mar; 338(2):306-19. PubMed ID: 15745752
[TBL] [Abstract][Full Text] [Related]
18. A second mechanism employed by artemisinins to suppress Plasmodium falciparum hinges on inhibition of hematin crystallization.
Ma W; Balta VA; West R; Newlin KN; Miljanić OŠ; Sullivan DJ; Vekilov PG; Rimer JD
J Biol Chem; 2021; 296():100123. PubMed ID: 33239360
[TBL] [Abstract][Full Text] [Related]
19. Heme polymerase activity and the stage specificity of antimalarial action of chloroquine.
Orjih AU
J Pharmacol Exp Ther; 1997 Jul; 282(1):108-12. PubMed ID: 9223546
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
